2026. FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS. Eureka Journal of Health Sciences & Medical Innovation. 2, 6 (Jun. 2026), 1–11.